President's Cancer Panel

The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "President's Cancer Panel" – news · newspapers · books · scholar · JSTOR (March 2014) (Learn how and when to remove this message)

The President's Cancer Panel is a three-person panel that reports to the president of the United States on the development and execution of the National Cancer Program. Members serve 3-year terms, and at least two of the three panel members must be distinguished scientists or physicians. The president appoints one of the members to a one-year chair position. The panel meets at least four times each year, and these meetings are open to the public.^[1] The Panel was established in 1971 by the National Cancer Act.^[2]

As of July 2022^[update], the panel consists of Elizabeth M. Jaffee, M.D., FACR, FAACP, (chair), Mitchel S. Berger, M.D., FACS, FAANS, and Carol L. Brown, M.D., FACOG, FACS. ^[3]